Skip to content
★ Sign in to follow
VS

Viktor Siewertz

IRLAB TherapeuticsIRLAB Therapeutics AB
Total declarations
10
Companies
2
▲ Purchases (6 ops.)
€350k
▼ Sales (1 ops.)
€32k

Latest filing published 27 Dec 2020 for IRLAB Therapeutics AB, €32k.

Filing timeline

BuySale
Viktor Siewertz

Insider track record

Disclosed buys
6
Disclosed sells
1
Signal history

Closed purchases

Market purchases
6

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Viktor Siewertz: trading record in brief

Viktor Siewertz discloses dealings in 2 companies, chiefly IRLAB Therapeutics and IRLAB Therapeutics AB. Over a trading history stretching from 24 February 2017 to 23 December 2020, the count stands at 10 filings.

Both buying and selling appear: 6 purchases worth €350k, against 1 sale worth €32k. On balance, insiders were net buyers of €318k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2020, the count stands at 1 purchase and 1 sale.

In size, the median ticket on the buying side is €8,981. Clusters matter here: 1 out of 4 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.

The latest filing, published on 27 December 2020, reports an open-market purchase of €32k in IRLAB Therapeutics AB. Typically, a trade is published a median of 1 day after it takes place. The regulation allows three business days to notify a trade (MAR article 19). These figures are compiled from regulatory filings published by Finansinspektionen. They describe what insiders did and are not a recommendation.

Companies and markets linked to Viktor Siewertz

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▼
    Ekonomichef/finanschef/finansdirektörExecutivesIRLAB Therapeutics AB
    327,750 SEK0FI-SE
    7,500 shares@ SEK 43.70AktieISIN SE0012675361FI:csv-b32178c5aa7ec9cbc4f7
  • ●
    CFOExecutivesIRLAB Therapeutics AB
    327,375 SEK0FI-SE
    12,125 shares@ SEK 27.0082.9% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-145fa5aacbeeea99b7b5
  • ●
    CFOExecutivesIRLAB Therapeutics AB
    67,500 SEK0FI-SE
    2,500 shares@ SEK 27.0017.1% of flowBTA (betald tecknad aktie)ISIN SE0013748332FI:csv-44096840c12d239c7bc7
  • ▲
    CFOExecutivesIRLAB Therapeutics
    63,560 SEK20FI-SE
    2,000 shares@ SEK 31.7813.1% of flowAktieISIN SE0012675361FI:csv-93aaef5dfbce1b585ed3
    Canonical exit: 4 Dec 2019 (T+90)
  • ▲
    CFO - Ekonomi/finanschefExecutivesIRLAB Therapeutics AB
    3M SEK0FI-SE
    9,615 shares@ SEK 312.01AktieISIN SE0009242225FI:csv-6a69f6ee186f5fe7b4ba
    Canonical exit: 10 Apr 2019 (T+90)
  • ▲
    COOExecutivesIRLAB Therapeutics
    72,255 SEK25FI-SE
    1,500 shares@ SEK 48.1716.7% of flowISIN SE0009242225FI:csv-6499cdd1b5b4e3dfdac0
    Canonical exit: 6 Jun 2017 (T+90)
  • ▲
    COOExecutivesIRLAB Therapeutics
    10,150 SEK11FI-SE
    200 shares@ SEK 50.752.3% of flowISIN SE0009242225FI:csv-a6ad29d5e367da85148a
    Canonical exit: 5 Jun 2017 (T+90)
  • ▲
    COOExecutivesIRLAB Therapeutics
    99,020 SEK13FI-SE
    2,000 shares@ SEK 49.5122.8% of flowISIN SE0009242225FI:csv-7b2d2871a71a5cb80190
    Canonical exit: 4 Jun 2017 (T+90)
  • ●
    COOExecutivesIRLAB Therapeutics
    195,180 SEK16FI-SE
    3,253 shares@ SEK 60.0045.1% of flowISIN SE0009242225FI:csv-eb5204fed9504cb0cda3

9 of 9 declarations